SCM
KMTS

Sterling Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Sterling Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.22K Buy
262
+38
+17% +$896 ﹤0.01% 2710
2025
Q4 		$5.94K Buy
224
+85
+61% +$2.19K ﹤0.01% 2832
2025
Q3 		$3.3K Buy
139
+68
+96% +$1.22K ﹤0.01% 2892
2025
Q2 		$1.18K Buy
+71
New +$1.55K ﹤0.01% 3036

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sterling Capital Management's KMTS Position: Q1 2026 in Review

Sterling Capital Management increased its Kestra Medical Technologies (KMTS) stake by 17% in Q1 2026, buying an estimated $896 and bringing the position to 262 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

Sterling Capital Management first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.94K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Sterling Capital Management held 262 shares of Kestra Medical Technologies worth $5.22K as of Q1 2026.
  • Sterling Capital Management bought 38 Kestra Medical Technologies shares in Q1 2026, an estimated $896.
  • Kestra Medical Technologies made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2710 holding.
  • Sterling Capital Management first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • Sterling Capital Management's Kestra Medical Technologies position peaked at $5.94K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.